Mylan takes hit over weak forecast; sector follows Street lower

BOSTON (MarketWatch) — Drug stocks followed the broader market lower early Friday as shares of Bristol-Myers Squibb and Sanofi-Aventis lost ground over jitters tied to a rival's plan to launch a gene…

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.